SLEEP NUMBER CORP
10-Ks and 10-Qs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the Quarterly Period Ended
June 30, 2018
Commission File Number: 0-25121
SLEEP NUMBER CORPORATION
(Exact name of registrant as specified in its charter)
|
Minnesota
|
|
41-1597886
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
1001 Third Avenue South
|
|
|
|
Minneapolis, Minnesota
|
|
55404
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code:
(763) 551-7000
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES
ý
NO
o
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). YES
ý
NO
o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
ý
|
|
|
Accelerated filer
o
|
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
|
Emerging growth company
o
|
||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES
o
NO
ý
As of
June 30, 2018
,
34,893,000
shares of the Registrant’s Common Stock were outstanding.
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
INDEX
|
|
Page
|
|
|
|
|
|
|
|
||
|
|
|
|
|
Item 1.
|
Financial Statements
(unaudited)
|
|
|
|
||
|
|
||
|
|
Condensed Consolidated Statements of Shareholders' (Deficit) Equity
|
|
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
|
|
|
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
Item 5.
|
||
|
Item 6.
|
||
ii
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
(unaudited - in thousands, except per share amounts)
|
|
June 30,
2018 |
|
December 30,
2017 |
||||
|
Assets
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
2,407
|
|
|
$
|
3,651
|
|
|
Accounts receivable, net of allowance for doubtful accounts of $547 and $714, respectively
|
22,065
|
|
|
19,312
|
|
||
|
Inventories
|
90,241
|
|
|
84,298
|
|
||
|
Income taxes receivable
|
6,527
|
|
—
|
|
|||
|
Prepaid expenses
|
10,580
|
|
|
17,565
|
|
||
|
Other current assets
|
26,399
|
|
|
27,665
|
|
||
|
Total current assets
|
158,219
|
|
|
152,491
|
|
||
|
|
|
|
|
|
|||
|
Non-current assets:
|
|
|
|
|
|||
|
Property and equipment, net
|
202,378
|
|
|
208,646
|
|
||
|
Goodwill and intangible assets, net
|
76,497
|
|
|
77,588
|
|
||
|
Deferred income taxes
|
—
|
|
2,625
|
|
|||
|
Other non-current assets
|
33,256
|
|
|
30,484
|
|
||
|
Total assets
|
$
|
470,350
|
|
|
$
|
471,834
|
|
|
|
|
|
|
|
|||
|
Liabilities and Shareholders’ (Deficit) Equity
|
|
|
|
|
|||
|
Current liabilities:
|
|
|
|
|
|||
|
Borrowings under revolving credit facility
|
$
|
182,500
|
|
$
|
24,500
|
|
|
|
Accounts payable
|
100,996
|
|
|
129,194
|
|
||
|
Customer prepayments
|
28,136
|
|
|
27,767
|
|
||
|
Accrued sales returns
|
16,527
|
|
19,270
|
|
|||
|
Compensation and benefits
|
24,688
|
|
|
34,602
|
|
||
|
Taxes and withholding
|
9,078
|
|
|
24,234
|
|
||
|
Other current liabilities
|
48,065
|
|
|
46,822
|
|
||
|
Total current liabilities
|
409,990
|
|
|
306,389
|
|
||
|
|
|
|
|
|
|||
|
Non-current liabilities:
|
|
|
|
|
|||
|
Deferred income taxes
|
4,587
|
|
—
|
|
|||
|
Other non-current liabilities
|
76,927
|
|
|
76,289
|
|
||
|
Total liabilities
|
491,504
|
|
|
382,678
|
|
||
|
|
|
|
|
|
|||
|
Shareholders’ (deficit) equity:
|
|
|
|
|
|||
|
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value; 142,500 shares authorized, 34,893 and 38,813 shares issued and outstanding, respectively
|
349
|
|
|
388
|
|
||
|
Additional paid-in capital
|
—
|
|
|
—
|
|
||
|
(Accumulated deficit) retained earnings
|
(21,503
|
)
|
|
88,768
|
|
||
|
Total shareholders’ (deficit) equity
|
(21,154
|
)
|
|
89,156
|
|
||
|
Total liabilities and shareholders’ (deficit) equity
|
$
|
470,350
|
|
|
$
|
471,834
|
|
See accompanying notes to condensed consolidated financial statements.
2
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
(unaudited - in thousands, except per share amounts)
|
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
|||||||||||
|
Net sales
|
$
|
316,338
|
|
$
|
284,673
|
|
$
|
704,971
|
|
$
|
678,572
|
|
|||
|
Cost of sales
|
127,450
|
|
108,054
|
|
278,606
|
|
255,494
|
|
|||||||
|
Gross profit
|
188,888
|
|
176,619
|
|
426,365
|
|
423,078
|
|
|||||||
|
|
|
|
|
|
|
||||||||||
|
Operating expenses:
|
|
|
|||||||||||||
|
Sales and marketing
|
151,106
|
|
144,498
|
|
323,023
|
|
313,764
|
|
|||||||
|
General and administrative
|
28,828
|
|
28,819
|
|
60,562
|
|
62,588
|
|
|||||||
|
Research and development
|
6,868
|
|
6,363
|
|
13,793
|
|
13,959
|
|
|||||||
|
Total operating expenses
|
186,802
|
|
179,680
|
|
397,378
|
|
390,311
|
|
|||||||
|
Operating income (loss)
|
2,086
|
|
(3,061
|
)
|
28,987
|
|
32,767
|
|
|||||||
|
Other expense, net
|
1,453
|
|
282
|
|
1,978
|
|
420
|
|
|||||||
|
Income (loss) before income taxes
|
633
|
|
(3,343
|
)
|
27,009
|
|
32,347
|
|
|||||||
|
Income tax (benefit) expense
|
(3,111
|
)
|
(2,565
|
)
|
2,717
|
|
8,664
|
|
|||||||
|
Net income (loss)
|
$
|
3,744
|
|
$
|
(778
|
)
|
$
|
24,292
|
|
$
|
23,683
|
|
|||
|
Basic net income (loss) per share:
|
|
|
|
|
|||||||||||
|
Net income (loss) per share – basic
|
$
|
0.10
|
|
$
|
(0.02
|
)
|
$
|
0.65
|
|
$
|
0.56
|
|
|||
|
Weighted-average shares – basic
|
36,138
|
|
41,716
|
|
37,191
|
|
42,233
|
|
|||||||
|
Diluted net income (loss) per share:
|
|
|
|
|
|||||||||||
|
Net income (loss) per share – diluted
|
$
|
0.10
|
|
$
|
(0.02
|
)
|
$
|
0.64
|
|
$
|
0.55
|
|
|||
|
Weighted-average shares – diluted
|
36,844
|
|
41,716
|
|
38,096
|
|
43,080
|
|
|||||||
See accompanying notes to condensed consolidated financial statements.
3
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Condensed Consolidated Statement of Shareholders’ (Deficit) Equity
(unaudited - in thousands)
|
|
Common Stock
|
Additional
Paid-in
Capital
|
Retained
Earnings
(Accumulated
Deficit)
|
Total
|
||||||||||||||
|
Shares
|
Amount
|
|||||||||||||||||
|
Balance at December 30, 2017
|
38,813
|
|
$
|
388
|
|
$
|
—
|
|
$
|
88,768
|
|
$
|
89,156
|
|
||||
|
Net income
|
—
|
|
—
|
|
—
|
|
24,292
|
|
24,292
|
|
||||||||
|
Exercise of common stock options
|
124
|
|
1
|
|
1,595
|
|
—
|
|
1,596
|
|
||||||||
|
Stock-based compensation
|
254
|
|
3
|
|
6,739
|
|
—
|
|
6,742
|
|
||||||||
|
Repurchases of common stock
|
(4,298
|
)
|
(43
|
)
|
(8,334
|
)
|
(134,563
|
)
|
(142,940
|
)
|
||||||||
|
Balance at June 30, 2018
|
34,893
|
|
$
|
349
|
|
$
|
—
|
|
$
|
(21,503
|
)
|
$
|
(21,154
|
)
|
||||
See accompanying notes to condensed consolidated financial statements.
4
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
(unaudited - in thousands)
|
Six Months Ended
|
|||||||
|
|
June 30,
2018 |
July 1,
2017 |
|||||
|
Cash flows from operating activities:
|
|
|
|||||
|
Net income
|
$
|
24,292
|
|
$
|
23,683
|
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
31,089
|
|
31,177
|
|
|||
|
Stock-based compensation
|
6,742
|
|
7,876
|
|
|||
|
Net loss on disposals and impairments of assets
|
15
|
|
2
|
|
|||
|
Deferred income taxes
|
7,212
|
|
4,974
|
|
|||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
(2,753
|
)
|
(4,781
|
)
|
|||
|
Inventories
|
(5,943
|
)
|
5,170
|
|
|||
|
Income taxes
|
(19,075
|
)
|
(14,532
|
)
|
|||
|
Prepaid expenses and other assets
|
8,242
|
|
2,110
|
|
|||
|
Accounts payable
|
(4,859
|
)
|
11,858
|
|
|||
|
Customer prepayments
|
369
|
|
19,518
|
|
|||
|
Accrued compensation and benefits
|
(9,944
|
)
|
9,834
|
|
|||
|
Other taxes and withholding
|
(2,608
|
)
|
(6,032
|
)
|
|||
|
Other accruals and liabilities
|
(3,648
|
)
|
(2,050
|
)
|
|||
|
Net cash provided by operating activities
|
29,131
|
|
88,807
|
|
|||
|
Cash flows from investing activities:
|
|
|
|||||
|
Purchases of property and equipment
|
(21,341
|
)
|
(27,132
|
)
|
|||
|
Proceeds from sales of property and equipment
|
70
|
|
—
|
|
|||
|
Net cash used in investing activities
|
(21,271
|
)
|
(27,132
|
)
|
|||
|
Cash flows from financing activities:
|
|
|
|
|
|||
|
Repurchases of common stock
|
(142,940
|
)
|
(80,094
|
)
|
|||
|
Net increase in short-term borrowings
|
133,253
|
|
3,098
|
|
|||
|
Proceeds from issuance of common stock
|
1,596
|
|
2,654
|
|
|||
|
Debt issuance costs
|
(1,013
|
)
|
(10
|
)
|
|||
|
Net cash used in financing activities
|
(9,104
|
)
|
(74,352
|
)
|
|||
|
Net decrease in cash, cash equivalents and restricted cash
|
(1,244
|
)
|
(12,677
|
)
|
|||
|
Cash, cash equivalents and restricted cash, at beginning of period
|
3,651
|
|
14,759
|
|
|||
|
Cash, cash equivalents and restricted cash, at end of period
|
$
|
2,407
|
|
$
|
2,082
|
|
|
See accompanying notes to condensed consolidated financial statements.
5
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
1. Business and Summary of Significant Accounting Policies
Business & Basis of Presentation
We prepared the condensed consolidated financial statements as of and for the
three and six months ended
June 30, 2018
of Sleep Number Corporation and 100%-owned subsidiaries (Sleep Number or the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) and they reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position as of
June 30, 2018
and
December 30, 2017
, and the consolidated results of operations and cash flows for the periods presented. Our historical and quarterly consolidated results of operations may not be indicative of the results that may be achieved for the full year or any future period.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with our most recent audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended
December 30, 2017
and other recent filings with the SEC.
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of sales, expenses and income taxes during the reporting period. Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the consolidated financial statements in future periods. Our critical accounting policies consist of stock-based compensation, goodwill and indefinite-lived intangible assets, warranty liabilities and revenue recognition.
The condensed consolidated financial statements include the accounts of Sleep Number Corporation and our 100%-owned subsidiaries. All significant intra-entity balances and transactions have been eliminated in consolidation.
New Accounting Pronouncements
Recently Adopted Accounting Guidance
Adoption of ASC Topic 230,
Restricted Cash
Effective December 31, 2017, we adopted ASC Topic 230,
Restricted Cash
, which requires amounts generally described as restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the total beginning and ending amounts for the periods shown on the statement of cash flows. Amounts for prior periods have been retrospectively adjusted to conform to the current period presentation.
Adoption of ASC Topic 606,
Revenue from Contracts with Customers
On December 31, 2017, we adopted ASC Topic 606,
Revenue from Contracts with Customers,
using the modified retrospective method applied to those contracts which were not completed as of December 30, 2017. Results for reporting periods beginning after December 30, 2017 are presented under the new guidance, while prior period amounts are not restated.
The cumulative effect of the changes made to our consolidated balance sheet as of December 31, 2017 resulting from the adoption of the new revenue guidance was not material and did not impact opening retained earnings. The impact on the timing of net sales for the three and six months ended June 30, 2018, as a result of applying the new guidance, was not material.
Practical expedients and exemptions permissible under ASC Topic 606 that we elected are as follows: we do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less; and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
See Note 2,
Revenue Recognition,
for further details regarding our revenue recognition policy.
6
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
Accounting Guidance Issued but Not Yet Adopted as of
June 30, 2018
In February 2016, the FASB issued ASC Topic 842,
Leases
, that requires most leases to be recognized on the balance sheet and expands disclosure requirements. The provisions of this new guidance permit us to utilize a prospective approach, with elective reliefs. We are the lessee under various agreements for facilities and equipment that are currently accounted for as operating leases. This new guidance is effective for us beginning December 30, 2018 and we are in the process of implementing a new lease accounting system in connection with the adoption. While we expect a material impact to our consolidated balance sheet as a result of the adoption of this new guidance, we continue to evaluate the effect of the new standard on our consolidated financial statements and related disclosures. We also expect that adoption of the new guidance will require changes to our internal controls over financial reporting.
2. Revenue Recognition
We recognize revenue when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Revenue recognized excludes sales taxes. Amounts billed to customers for delivery and setup are included in net sales. For most products, we require payment before the products or services are delivered to the customer.
Our beds sold with SleepIQ
®
technology contain multiple performance obligations including the bed and SleepIQ’s hardware and software. We analyze our multiple performance obligation(s) to determine whether they are distinct and can be separated or whether they must be accounted for as a single performance obligation. We determined that the beds sold with the SleepIQ technology have two performance obligations consisting of: (i) the bed; and (ii) SleepIQ's hardware and software. SleepIQ’s hardware and software are not separable as the hardware and related software are not sold separately and the software is integral to the hardware’s functionality. We determine the transaction price for multiple performance obligations based on their relative standalone selling prices. The performance obligation related to the bed is satisfied at a point in time. The performance obligation related to SleepIQ technology is satisfied over time based on the ongoing access and usage by the customer of software essential to the functionality of SleepIQ technology. The deferred revenue and costs related to SleepIQ technology are recognized on a straight-line basis over the product’s estimated life of
four years
because our inputs are generally expended evenly throughout the performance period.
At
June 30, 2018
and
December 30, 2017
, we had deferred contract liabilities of
$71 million
and
$73 million
, of which
$31 million
and
$30 million
are included in other current liabilities, respectively, and
$40 million
and
$43 million
are included in other non-current liabilities, respectively, in our consolidated balance sheets. We also had deferred contract assets of
$45 million
and
$43 million
, of which
$19 million
and
$17 million
are included in other current assets, respectively, and
$26 million
and
$26 million
are included in other non-current assets, respectively, in our consolidated balance sheets. During the
three and six months ended
June 30, 2018
, we recognized revenue of
$8 million
and
$16 million
, respectively, that was included in the deferred contract liability balance at the beginning of the period.
Revenue from goods and services transferred to customers at a point in time accounted for approximately
97%
and
98%
of our revenues for the
three and six months ended
June 30, 2018
, respectively.
Net sales from each of our channels was as follows (in thousands):
|
|
Three Months Ended
|
Six Months Ended
|
||||||
|
|
June 30,
2018 |
June 30,
2018 |
||||||
|
Retail
|
$
|
286,853
|
|
$
|
642,922
|
|
||
|
Online and phone
|
24,927
|
|
52,894
|
|
||||
|
Company-Controlled channel
|
311,780
|
|
695,816
|
|
||||
|
Wholesale/Other channel
|
4,558
|
|
9,155
|
|
||||
|
Total
|
$
|
316,338
|
|
$
|
704,971
|
|
||
7
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
Obligation for Sales Returns
We accept sales returns during a 100-night trial period. Accrued sales returns represents a refund liability for the amount of consideration that we do not expect to be entitled to because it will be refunded to customers. The refund liability estimate is based on historical return rates and is adjusted for any current trends as appropriate. Each reporting period we remeasure the liability to reflect changes in the estimate, with a corresponding adjustment to net sales. The activity in the sales returns liability account was as follows (in thousands):
|
|
Six Months Ended
|
||||||
|
|
June 30,
2018 |
July 1,
2017 |
|||||
|
Balance at beginning of year
|
$
|
19,270
|
|
$
|
15,222
|
|
|
|
Additions that reduce net sales
|
36,555
|
|
32,434
|
|
|||
|
Deductions from reserves
|
(39,298
|
)
|
(35,054
|
)
|
|||
|
Balance at end of period
|
$
|
16,527
|
|
$
|
12,602
|
|
|
3. Fair Value Measurements
At
June 30, 2018
and
December 30, 2017
, we had
$5 million
and
$4 million
, respectively, of debt and equity securities that fund our deferred compensation plan and are classified in other non-current assets. We also had corresponding deferred compensation plan liabilities of
$5 million
and
$4 million
at
June 30, 2018
and
December 30, 2017
, respectively, which are included in other non-current liabilities. The majority of the debt and equity securities are Level 1 as they trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis. Unrealized gains/(losses) on the debt and equity securities offset those associated with the corresponding deferred compensation plan liabilities.
4. Inventories
Inventories consisted of the following (in thousands):
|
|
June 30,
2018 |
December 30,
2017 |
|||||
|
Raw materials
|
$
|
4,285
|
|
$
|
6,577
|
|
|
|
Work in progress
|
214
|
|
170
|
|
|||
|
Finished goods
|
85,742
|
|
77,551
|
|
|||
|
|
$
|
90,241
|
|
$
|
84,298
|
|
|
8
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
5. Goodwill and Intangible Assets, Net
Goodwill and Indefinite-Lived Intangible Assets
Goodwill was
$64 million
at
June 30, 2018
and
December 30, 2017
. Indefinite-lived trade name/trademarks totaled
$1.4 million
at
June 30, 2018
and
December 30, 2017
.
Definite-Lived Intangible Assets
The following table provides the gross carrying amount and related accumulated amortization of our definite-lived intangible assets (in thousands):
|
June 30, 2018
|
December 30, 2017
|
||||||||||||||
|
Gross Carrying
Amount
|
Accumulated
Amortization
|
Gross Carrying
Amount
|
Accumulated
Amortization
|
||||||||||||
|
Developed technologies
|
$
|
18,851
|
|
$
|
7,796
|
|
$
|
18,851
|
|
$
|
6,705
|
|
|||
|
Trade names/trademarks
|
101
|
|
101
|
|
101
|
|
101
|
|
|||||||
|
$
|
18,952
|
|
$
|
7,897
|
|
$
|
18,952
|
|
$
|
6,806
|
|
||||
Amortization expense for the
three months ended
June 30, 2018
and
July 1, 2017
, was
$0.5 million
and
$0.5 million
, respectively. Amortization expense for the
six months ended
June 30, 2018
and
July 1, 2017
, was
$1.1 million
and
$2.1 million
, respectively.
6. Credit Agreement
Our
$300 million
credit facility is for general corporate purposes and is also utilized to meet our seasonal working capital requirements. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio and a minimum interest coverage ratio. Under the terms of the credit agreement we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit agreement includes an accordion feature which allows us to increase the amount of the credit facility from
$300 million
to
$450 million
, subject to lenders' approval. The credit agreement matures in
February 2023
. We were in compliance with all financial covenants as of
June 30, 2018
.
The following tables summarizes our borrowings under the credit facility ($ in thousands):
|
|
June 30,
2018 |
December 30,
2017 |
|||||
|
Outstanding borrowings
|
$
|
182,500
|
|
$
|
24,500
|
|
|
|
Outstanding letters of credit
|
$
|
3,450
|
|
$
|
3,150
|
|
|
|
Additional borrowing capacity
|
$
|
114,050
|
|
$
|
125,500
|
|
|
|
Weighted-average interest rate
|
3.6
|
%
|
3.1
|
%
|
|||
9
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
7. Repurchase of Common Stock
Repurchases of our common stock were as follows (in thousands):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||||||
|
Amount repurchased under Board-approved share repurchase program
|
$
|
65,000
|
|
$
|
25,000
|
|
$
|
140,000
|
|
$
|
75,000
|
|
||||
|
Amount repurchased in connection with the vesting of employee restricted stock grants
|
292
|
|
300
|
|
2,940
|
|
5,094
|
|
||||||||
|
Total amount repurchased
|
$
|
65,292
|
|
$
|
25,300
|
|
$
|
142,940
|
|
$
|
80,094
|
|
||||
As of
June 30, 2018
, the remaining authorization under our Board-approved share repurchase program was
$325 million
. There is no expiration date governing the period over which we can repurchase shares. Any repurchased shares are constructively retired and returned to an unissued status.
The cost of stock repurchases is first charged to additional paid-in capital. Once additional paid-in capital is reduced to zero, any additional amounts are charged to (accumulated deficit) retained earnings.
8. Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||||||
|
Stock awards
|
$
|
2,996
|
|
$
|
3,584
|
|
$
|
5,488
|
|
$
|
6,720
|
|
||||
|
Stock options
|
662
|
|
588
|
|
1,254
|
|
1,156
|
|
||||||||
|
Total stock-based compensation expense
|
3,658
|
|
4,172
|
|
6,742
|
|
7,876
|
|
||||||||
|
Income tax benefit
|
896
|
|
1,406
|
|
1,652
|
|
2,654
|
|
||||||||
|
Total stock-based compensation expense, net of tax
|
$
|
2,762
|
|
$
|
2,766
|
|
$
|
5,090
|
|
$
|
5,222
|
|
||||
9. Profit Sharing and 401(k) Plan
Under our profit sharing and 401(k) plan, eligible employees may defer up to
50%
of their compensation on a pre-tax basis, subject to Internal Revenue Service limitations. Each pay period, we may make a discretionary contribution equal to a percentage of the employee’s contribution. During the
three months ended
June 30, 2018
and
July 1, 2017
, our contributions, net of forfeitures, were
$1.3 million
and
$1.2 million
, respectively. During the
six months ended
June 30, 2018
and
July 1, 2017
, our contributions, net of forfeitures, were
$2.7 million
and
$2.5 million
, respectively.
10. Other Expense, Net
Other expense, net, consisted of the following (in thousands):
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
|||||||||||
|
Interest expense
|
$
|
(1,454
|
)
|
$
|
(288
|
)
|
$
|
(1,981
|
)
|
$
|
(470
|
)
|
|||
|
Interest income
|
1
|
|
6
|
|
3
|
|
50
|
|
|||||||
|
Other expense, net
|
$
|
(1,453
|
)
|
$
|
(282
|
)
|
$
|
(1,978
|
)
|
$
|
(420
|
)
|
|||
10
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
11. Net Income (Loss) per Common Share
The components of basic and diluted net income (loss) per share were as follows (in thousands, except per share amounts):
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
|||||||||||
|
Net income (loss)
|
$
|
3,744
|
|
$
|
(778
|
)
|
$
|
24,292
|
|
$
|
23,683
|
|
|||
|
Reconciliation of weighted-average shares outstanding:
|
|
|
|||||||||||||
|
Basic weighted-average shares outstanding
|
36,138
|
|
41,716
|
|
37,191
|
|
42,233
|
|
|||||||
|
Dilutive effect of stock-based awards
|
706
|
|
—
|
|
905
|
|
847
|
|
|||||||
|
Diluted weighted-average shares outstanding
|
36,844
|
|
41,716
|
|
38,096
|
|
43,080
|
|
|||||||
|
Net income (loss) per share – basic
|
$
|
0.10
|
|
$
|
(0.02
|
)
|
$
|
0.65
|
|
$
|
0.56
|
|
|||
|
Net income (loss) per share – diluted
|
$
|
0.10
|
|
$
|
(0.02
|
)
|
$
|
0.64
|
|
$
|
0.55
|
|
|||
For the three months ended June 30, 2018 and the six months ended
June 30, 2018
and
July 1, 2017
, anti-dilutive stock-based awards excluded from the diluted net income per share calculations were immaterial. For the three months ended July 1, 2017, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.
12. Income Taxes
As a result of the enactment of the Tax Cuts and Jobs Act (TCJA), we recorded a provisional tax benefit of
$1.7 million
in the fourth quarter of 2017 based on our initial analysis of the TCJA using the best information and estimates available. During the second quarter 2018, we updated our provisional tax benefit based on new information, including a tax planning analysis, and recorded an additional
$2.9 million
provisional tax benefit.
Due to the significant complexity of the TCJA, anticipated further guidance from the U.S. Treasury, the potential for additional guidance from the SEC/ FASB, or other new information becoming available, our provisional tax benefit may be further adjusted during 2018. Our provisional estimate is expected to be finalized no later than the fourth quarter of 2018. Further guidance and additional information regarding the TCJA may also impact our 2018 effective income tax rate, exclusive of any adjustment to the provisional tax benefit.
13. Commitments and Contingencies
Warranty Liabilities
The activity in the accrued warranty liabilities account was as follows (in thousands):
|
|
Six Months Ended
|
||||||
|
|
June 30,
2018 |
July 1,
2017 |
|||||
|
Balance at beginning of year
|
$
|
9,320
|
|
$
|
8,633
|
|
|
|
Additions charged to costs and expenses for current-year sales
|
6,106
|
|
4,243
|
|
|||
|
Deductions from reserves
|
(5,790
|
)
|
(3,665
|
)
|
|||
|
Changes in liability for pre-existing warranties during the current year, including expirations
|
132
|
|
(55
|
)
|
|||
|
Balance at end of period
|
$
|
9,768
|
|
$
|
9,156
|
|
|
11
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements
(unaudited)
Legal Proceedings
We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with generally accepted accounting principles in the United States, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible additional losses either because we believe that we have valid defenses to claims asserted against us or the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate. We currently do not expect the outcome of these matters to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.
On January 12, 2015, Plaintiffs David and Katina Spade commenced a purported class action lawsuit in New Jersey state court against Sleep Number alleging that Sleep Number violated New Jersey consumer statutes by failing to provide to purchasing consumers certain disclosures required by the New Jersey Furniture Regulations. It is undisputed that plaintiffs suffered no actual damages or in any way relied upon or were impacted by the alleged omissions. Nonetheless, on behalf of a purported class of New Jersey purchasers of Sleep Number beds and bases, plaintiffs seek to recover a $100 statutory fine for each alleged omission, along with attorneys’ fees and costs. Sleep Number removed the case to the United States District Court for the District of New Jersey, which subsequently granted Sleep Number’s motion to dismiss. Plaintiffs appealed to the United States Court of Appeals for the Third Circuit, which certified two questions of law to the New Jersey Supreme Court relating to whether plaintiffs who have suffered no actual injury may bring claims. The New Jersey Supreme Court accepted the certified questions and on April 16, 2018, ruled in our favor on one of the two questions, holding that a consumer only has standing to bring a claim under the relevant statute if the consumer has been harmed by the defendant's conduct. The Third Circuit has remanded the case to the federal district court for further analysis consistent with the New Jersey Supreme Court’s opinion. As a result, we expect that the federal district court will dismiss any claims that Plaintiffs attempt to pursue consistent with the guidance set forth by the New Jersey Supreme Court.
12
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a reader of our consolidated financial statements with a narrative from the perspective of management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in seven sections:
|
•
|
Risk Factors
|
|
•
|
Company Overview
|
|
•
|
Results of Operations
|
|
•
|
Liquidity and Capital Resources
|
|
•
|
Non-GAAP Data
|
|
•
|
Off-Balance-Sheet Arrangements and Contractual Obligations
|
|
•
|
Critical Accounting Policies
|
Risk Factors
The following discussion and analysis should be read in conjunction with the Condensed Consolidated Financial Statements and the Notes thereto included herein. This quarterly report on Form 10-Q contains certain forward-looking statements that relate to future plans, events, financial results or performance. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or the negative of these or similar terms. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections.
These risks and uncertainties include, among others:
|
•
|
Current and future general and industry economic trends and consumer confidence;
|
|
•
|
The effectiveness of our marketing messages;
|
|
•
|
The efficiency of our advertising and promotional efforts;
|
|
•
|
Our ability to execute our Company-Controlled distribution strategy;
|
|
•
|
Our ability to achieve and maintain acceptable levels of product and service quality, and acceptable product return and warranty claims rates;
|
|
•
|
Our ability to continue to improve and expand our product line, and consumer acceptance of our products, product quality, innovation and brand image;
|
|
•
|
Industry competition, the emergence of additional competitive products and the adequacy of our intellectual property rights to protect our products and brand from competitive or infringing activities;
|
|
•
|
The potential for claims that our products, processes, advertising or trademarks infringe the intellectual property rights of others;
|
|
•
|
Availability of attractive and cost-effective consumer credit options;
|
|
•
|
Shortages in supply due to “just-in-time” manufacturing processes with minimal levels of inventory utilized for some of our products, or due to global shortages of electronic componentry;
|
|
•
|
Our dependence on significant suppliers and our ability to maintain relationships with key suppliers, including several sole-source suppliers;
|
|
•
|
Rising commodity costs and other inflationary pressures;
|
|
•
|
Risks inherent in global sourcing activities, including the potential for shortages in supply;
|
|
•
|
Risks of disruption in the operation of either of our two main manufacturing facilities;
|
|
•
|
Increasing government regulation and the costs of compliance and risks of non-compliance with existing and new regulations;
|
|
•
|
Pending or unforeseen litigation and the potential for adverse publicity associated with litigation;
|
|
•
|
The adequacy of our management information systems to meet the evolving needs of our business and existing and evolving regulatory standards applicable to data privacy and security;
|
|
•
|
The costs and potential disruptions to our business related to upgrading our management information systems;
|
|
•
|
The vulnerability of our management information systems to attacks by hackers or other cyber threats that could compromise the security of our systems, result in a data breach or disrupt our business; and
|
|
•
|
Our ability to attract, retain and motivate qualified management, executive and other key employees, including qualified retail sales professionals and managers.
|
Additional information concerning these and other risks and uncertainties is contained under the caption “Risk Factors” in our Annual Report on Form 10-K.
We have no obligation to publicly update or revise any of the forward-looking statements contained in this quarterly report on Form 10-Q.
13
Company Overview
Sleep Number Corporation, based in Minneapolis, Minnesota, was founded in 1987. We are listed on The NASDAQ Stock Market LLC (NASDAQ Global Select Market) under the symbol “SNBR.”
Our mission is to improve lives by individualizing sleep experiences. Our vision is to become one of the world's most beloved brands
by delivering an unparalleled sleep experience. We plan to achieve this by executing our Consumer Innovation Strategy, which includes three significant competitive advantages: proprietary sleep innovations, lifelong customer relationships and exclusive retail distribution.
We have a direct-to-consumer, vertically integrated business model and are the exclusive designer, manufacturer, marketer, retailer and servicer of Sleep Number® beds. We offer consumers high-quality, individualized sleep solutions and services, including a complete line of Sleep Number beds, bases and bedding accessories. We are the pioneer in biometric sleep tracking and adjustability. SleepIQ® technology is a proprietary sensor technology that tracks each individual’s sleep and uses algorithms to automatically adjust the comfort level of each sleeper by working directly with our bed’s DualAir™ system. Through daily digital interactions that build lifelong relationships, SleepIQ technology also communicates how you slept and provides insights on what adjustments you can make to optimize your sleep and improve your daily life. Sleep Number also offers FlexFit™ adjustable bases, and Sleep Number pillows, sheets and other bedding products. As a national specialty mattress retailer, we provide customers a cohesive experience across our Sleep Number stores, online at SleepNumber.com or via phone at (800)753-3768.
We are committed to delivering superior shareholder value through three primary drivers of earnings per share growth: increasing
consumer demand, leveraging our business model and deploying capital efficiently. As the sleep innovation leader, we drive
growth through effective brand marketing, our proprietary innovations and a differentiated retail experience.
We generate revenue by marketing our innovations to new and existing customers, and selling products directly to consumers through Stores, Online, Chat and Phone, which we reference as our Company-Controlled channel. We also have a small Wholesale business in the United States.
We are the only vertically integrated bed manufacturer/retailer in the U.S. We have two manufacturing plants that distribute Sleep
Number products. We offer mattress home delivery and installation, and maintain an in-house customer service department. This
integration enables operational synergies and efficiencies, and a strong working capital position. Vertical integration allows us to build
a long-term loyal customer relationship as we service the consumer through the full purchase and ownership cycle. This relationship
with our customer creates a productive cycle of referral and repeat business.
Results of Operations
Quarterly and Year-to-Date Results
Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including increases or decreases in sales, the timing, amount and effectiveness of advertising expenditures, changes in sales return rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/closings and related expenses, changes in net sales resulting from changes in our store base, the timing of new product introductions and related expenses, the timing of promotional offerings, competitive factors, changes in commodity costs, any disruptions in supplies or third-party service providers, seasonality of retail and bedding industry sales, consumer confidence and general economic conditions. Therefore, our historical results of operations may not be indicative of the results that may be achieved for any future period.
Highlights
Financial highlights for the period ended
June 30, 2018
were as follows:
|
•
|
Net sales for the
three months ended
June 30, 2018
increased
11%
to
$316 million
, compared with
$285 million
for the same period one year ago. Net sales for the comparable period one year ago were affected by an approximately $25 million shift in sales from our second quarter to our third quarter as a result of a delay in deliveries and shipments related to an inventory shortage at a new supplier.
|
|
•
|
The
11%
sales
increase
resulted from a
9%
comparable sales
increase
in our Company-Controlled channel and
3
percentage points (ppt.) of growth from sales generated by
16
net new stores opened in the past 12 months.
|
|
•
|
The transition to our full line of Sleep Number 360
®
smart beds continued during the quarter and is now complete. In May 2017, we began selling our i7 and i10 smart beds. We launched a third smart bed model (the p6) in December 2017. In April 2018, we
|
14
introduced the Sleep Number 360 p5 and i8 smart beds, our two most popular models. Our c4 and c2 models completed the transition in June and July 2018, respectively. The Sleep Number 360 smart bed won 13 awards at CES 2017, including being named the Best of Innovation Honoree in the Home Appliance category. It also received the 2018 Edison Silver Award for breakthrough product design and innovation in the Wellness Technology category.
|
•
|
Sales per store (Company-Controlled channel sales for stores open at least one year) on a trailing twelve-month basis for the period ended
June 30, 2018
totaled
$2.6 million
, 4% higher than the same period one-year ago.
|
|
•
|
Operating income for the three months ended June 30, 2018 was
$2 million
, a
$5 million
increase from an operating loss of
$3 million
for the prior-year period. Our operating income rate increased to
0.7%
of net sales, compared with an operating loss rate of
1.1%
of net sales for the same period last year. The current-period's operating income rate benefited from operating expense controls and sales leverage which mitigated the lower gross profit rate. Prior year's operating loss was affected by the sales shift discussed above.
|
|
•
|
Net income for the three months ended June 30, 2018 was
$4 million
, or
$0.10
per diluted share, compared with a net loss of
$1 million
, or
$(0.02)
per diluted share, for the same period one year ago. The current quarter includes a one-time tax planning benefit of $2.9 million, or $0.08 per diluted share, associated with the new Tax Cuts and Jobs Act.
|
|
•
|
Cash provided by operating activities totaled
$29 million
for the
six months ended
June 30, 2018
, compared with
$89 million
for the same period one year ago. The largest drivers in the year-over-year change in operating cash flows resulted from the timing of performance-based incentive compensation payments and expenses, fluctuations in customer prepayments resulting from higher than normal prepayments at July 1, 2017 (delayed deliveries and shipments due to an inventory shortage from one of our new suppliers) and year-over-year changes in inventory levels. Investing activities for the current-year period included
$21 million
of property and equipment purchases, compared with
$27 million
for the same period last year.
|
|
•
|
At
June 30, 2018
, cash and cash equivalents totaled
$2 million
and we ended the quarter with
$183 million
of borrowings under our
$300 million
revolving credit facility.
|
|
•
|
In the
second
quarter of
2018
, we repurchased
2.1 million
shares of our common stock under our Board-approved share repurchase program at a cost of
$65 million
(an average of
$30.36
per share). As of June 30, 2018, the remaining authorization under our Board-approved share repurchase program was $325 million.
|
The following table sets forth our results of operations expressed as dollars and percentages of net sales. Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||||||||||||||||||
|
Net sales
|
$
|
316.3
|
|
100.0
|
%
|
$
|
284.7
|
|
100.0
|
%
|
$
|
705.0
|
|
100.0
|
%
|
$
|
678.6
|
|
100.0
|
%
|
||||||||
|
Cost of sales
|
127.5
|
|
40.3
|
%
|
108.1
|
|
38.0
|
%
|
278.6
|
|
39.5
|
%
|
255.5
|
|
37.7
|
%
|
||||||||||||
|
Gross profit
|
188.9
|
|
59.7
|
%
|
176.6
|
|
62.0
|
%
|
426.4
|
|
60.5
|
%
|
423.1
|
|
62.3
|
%
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||||||||||||||
|
Sales and marketing
|
151.1
|
|
47.8
|
%
|
144.5
|
|
50.8
|
%
|
323.0
|
|
45.8
|
%
|
313.8
|
|
46.2
|
%
|
||||||||||||
|
General and administrative
|
28.8
|
|
9.1
|
%
|
28.8
|
|
10.1
|
%
|
60.6
|
|
8.6
|
%
|
62.6
|
|
9.2
|
%
|
||||||||||||
|
Research and development
|
6.9
|
|
2.2
|
%
|
6.4
|
|
2.2
|
%
|
13.8
|
|
2.0
|
%
|
14.0
|
|
2.1
|
%
|
||||||||||||
|
Total operating expenses
|
186.8
|
|
59.1
|
%
|
179.7
|
|
63.1
|
%
|
397.4
|
|
56.4
|
%
|
390.3
|
|
57.5
|
%
|
||||||||||||
|
Operating income
|
2.1
|
|
0.7
|
%
|
(3.1
|
)
|
(1.1
|
%)
|
29.0
|
|
4.1
|
%
|
32.8
|
|
4.8
|
%
|
||||||||||||
|
Other expense, net
|
1.5
|
|
0.5
|
%
|
0.3
|
|
0.1
|
%
|
2.0
|
|
0.3
|
%
|
0.4
|
|
0.1
|
%
|
||||||||||||
|
Income before income taxes
|
0.6
|
|
0.2
|
%
|
(3.3
|
)
|
(1.2
|
%)
|
27.0
|
|
3.8
|
%
|
32.3
|
|
4.8
|
%
|
||||||||||||
|
Income tax (benefit) expense
|
(3.1
|
)
|
(1.0
|
%)
|
(2.6
|
)
|
(0.9
|
%)
|
2.7
|
|
0.4
|
%
|
8.7
|
|
1.3
|
%
|
||||||||||||
|
Net income
|
$
|
3.7
|
|
1.2
|
%
|
$
|
(0.8
|
)
|
(0.3
|
%)
|
$
|
24.3
|
|
3.4
|
%
|
$
|
23.7
|
|
3.5
|
%
|
||||||||
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Basic
|
$
|
0.10
|
|
|
|
$
|
(0.02
|
)
|
$
|
0.65
|
|
$
|
0.56
|
|
|
|
||||||||||||
|
Diluted
|
$
|
0.10
|
|
|
|
$
|
(0.02
|
)
|
$
|
0.64
|
|
$
|
0.55
|
|
|
|
||||||||||||
|
Weighted-average number of common shares:
|
|
|
|
|
||||||||||||||||||||||||
|
Basic
|
36.1
|
|
|
|
41.7
|
|
37.2
|
|
42.2
|
|
|
|
||||||||||||||||
|
Diluted
|
36.8
|
|
|
|
41.7
|
|
38.1
|
|
43.1
|
|
|
|
||||||||||||||||
15
The percentage of our total net sales, by dollar volume, from each of our channels was as follows:
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||
|
Company-Controlled channel
|
98.6
|
%
|
97.7
|
%
|
98.7
|
%
|
98.0
|
%
|
||||
|
Wholesale/Other channel
|
1.4
|
%
|
2.3
|
%
|
1.3
|
%
|
2.0
|
%
|
||||
|
Total
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||
The components of total net sales change, including comparable net sales changes, were as follows:
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||
|
Sales change rates:
|
|
|
|
|
||||||||
|
Retail comparable-store sales
(1)
|
8
|
%
|
(6
|
%)
|
1
|
%
|
(1
|
%)
|
||||
|
Online and phone
|
19
|
%
|
26
|
%
|
12
|
%
|
22
|
%
|
||||
|
Company-Controlled comparable sales change
|
9
|
%
|
(4
|
%)
|
2
|
%
|
0
|
%
|
||||
|
Net opened/closed stores
|
3
|
%
|
8
|
%
|
3
|
%
|
9
|
%
|
||||
|
Total Company-Controlled channel
|
12
|
%
|
4
|
%
|
5
|
%
|
9
|
%
|
||||
|
Wholesale/Other channel
|
(29
|
%)
|
(31
|
%)
|
(33
|
%)
|
(27
|
%)
|
||||
|
Total net sales change
|
11
|
%
|
3
|
%
|
4
|
%
|
8
|
%
|
||||
(1)
Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned within the same shopping center remain in the comparable-store base.
Other sales metrics were as follows:
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||||||
|
Average sales per store
(1)
($ in thousands)
|
$
|
2,645
|
|
$
|
2,535
|
|
|
|
||||||||
|
Average sales per square foot
(1)
|
$
|
985
|
|
$
|
983
|
|
|
|
||||||||
|
Stores > $1 million in net sales
(2)
|
98
|
%
|
97
|
%
|
||||||||||||
|
Stores > $2 million in net sales
(2)
|
63
|
%
|
58
|
%
|
|
|
||||||||||
|
Average revenue per mattress unit –
Company-Controlled channel
(3)
|
$
|
4,508
|
|
$
|
4,306
|
|
$
|
4,459
|
|
$
|
4,155
|
|
||||
(1)
Trailing twelve months Company-Controlled comparable sales per store open at least one year.
(2)
Trailing-twelve months for stores open at least one year.
(3)
Represents Company-Controlled channel total net sales divided by Company-Controlled channel mattress units.
The number of retail stores operating was as follows:
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||
|
Beginning of period
|
558
|
|
546
|
|
556
|
|
540
|
|
||||
|
Opened
|
11
|
|
8
|
|
24
|
|
24
|
|
||||
|
Closed
|
(4
|
)
|
(5
|
)
|
(15
|
)
|
(15
|
)
|
||||
|
End of period
|
565
|
|
549
|
|
565
|
|
549
|
|
||||
16
Comparison of Three Months Ended
June 30, 2018
with Three Months Ended
July 1, 2017
Net sales
Net sales
increased
11%
to
$316 million
for the three months ended
June 30, 2018
, compared with
$285 million
for the same period one year ago. Net sales for the comparable period one year ago were affected by an approximately $25 million shift in sales from our second quarter to our third quarter as a result of a delay in deliveries and shipments related to an inventory shortage at a new supplier.
The
11%
sales
increase
resulted from a
9%
comparable sales
increase
in our Company-Controlled channel and
3
percentage points (ppt.) of growth from sales generated by
16
net new stores opened in the past 12 months.
The
$32 million
net sales increase compared with the same period one year ago was comprised of the following: (i) a $25 million increase in our Company-Controlled comparable net sales; and (ii) a $9 million increase resulting from net store openings; partially offset by (iii) a $2 million decrease in Wholesale/Other channel sales. Company-Controlled mattress unit sales increased 7% compared with the prior year. Average revenue per mattress unit in our Company-Controlled channel increased by
5%
to
$4,508
.
The transition to our full line of Sleep Number 360
®
smart beds continued during the quarter and is now complete. In May 2017, we began selling our i7 and i10 smart beds. We launched a third smart bed model (the p6) in December 2017. In April 2018, we introduced the Sleep Number 360 p5 and i8 smart beds, our two most popular models. Our c4 and c2 models completed the transition in June and July 2018, respectively. The Sleep Number 360 smart bed won 13 awards at CES 2017, including being named the Best of Innovation Honoree in the Home Appliance category. It also received the 2018 Edison Silver Award for breakthrough product design and innovation in the Wellness Technology category.
Gross profit
Gross profit of
$189 million
increased
by
$12 million
, or
7%
, compared with
$177 million
for the same period one year ago. The gross profit rate was
59.7%
of net sales for the three months ended
June 30, 2018
, compared with
62.0%
for the prior-year comparable period. The current-year gross profit rate decline of
2.3
ppt. was primarily due to: (i) 1.2 ppt. of temporary inefficiencies resulting from operating two product lines and closeout sales; and (ii) 1.1 ppt. mainly due to a higher mix of lower-margin sourced products, including FlexFit™ adjustable bases, and inflation impacts. These inefficiencies or transition costs included higher freight and logistics costs, and supplier transition expenses. In addition, our gross profit rate will fluctuate from quarter to quarter due to a variety of other factors, including warranty expenses, return and exchange costs, and performance-based incentive compensation.
Sales and marketing expenses
Sales and marketing expenses for the three months ended
June 30, 2018
increased to
$151 million
, or
47.8%
of net sales, compared with
$144 million
, or
50.8%
of net sales, for the same period one year ago. The
3.0
ppt. decrease in the sales and marketing expense rate was mainly due to the leveraging impact of the
11%
net sales increase (see net sales commentary above).
General and administrative expenses
General and administrative (G&A) expenses totaled
$29 million
, consistent with the prior-year period. During the three months ended June 30, 2018, a $0.6 million increase in employee compensation resulting primarily from salary and wage rate changes that were in line with inflation were offset by a decrease in miscellaneous other expenses. The G&A expense rate decreased by
1.0
ppt. to
9.1%
of net sales in the current-year period compared with
10.1%
for the same period one year ago due to the leveraging impact of the
11%
net sales increase (see net sales commentary above).
Income tax benefit
Income tax benefit was
$3.1 million
for the
three months ended
June 30, 2018
, compared with
$2.6 million
in the same period one year ago. The income tax benefit and effective income tax rate for the
three months ended
June 30, 2018
was impacted by changes associate with the Tax Cuts and Jobs Act, including a $2.9 million increase in the 2017 provisional tax benefit. See Note 12,
Income Taxes
, for further information.
17
Comparison of
Six Months Ended
June 30, 2018
with
Six Months Ended
July 1, 2017
Net sales
Net sales increased
4%
to
$705 million
for the
six months ended
June 30, 2018
, compared with
$679 million
for the same period one year ago. Net sales for the comparable period one year ago were affected by an approximately $25 million shift in sales from our second quarter to our third quarter as a result of a delay in deliveries and shipments related to an inventory shortage at a new supplier. The sales change was comprised of
3
percentage points (ppt.) of growth from sales generated by
16
net new stores opened in the past 12 months and a 2% comparable sales increase in our Company-Controlled channel, partially offset by a decrease in Wholesale/Other channel sales.
The
$26 million
net sales increase compared with the same period one year ago was comprised of the following: (i) an $18 million increase resulting from net store openings; and (ii) a $13 million increase in sales from our Company-Controlled comparable sales; partially offset by (iii) a $5 million decrease in Wholesale/Other channel sales. Company-Controlled mattress units decreased
2%
compared to the prior-year period. Average revenue per mattress unit in our Company-Controlled channel increased by
7%
.
Gross profit
Gross profit of
$426 million
for the
six months ended
June 30, 2018
increased by
$3 million
, or
1%
, compared with $423 million for the same period one year ago. The gross profit rate decreased to
60.5%
of net sales for the first six months of 2018, compared with
62.3%
for the prior-year period. The current-year gross profit rate decline of
1.8
ppt. was primarily due to: (i) 1.1 ppt. from a higher mix of lower-margin sourced products, including FlexFit™ adjustable bases; and (ii) 0.7 ppt. resulting primarily from temporary inefficiencies resulting from operating two product lines and closeout sales. In addition, our gross profit rate will fluctuate from quarter to quarter due to a variety of other factors, including warranty expenses, return and exchange costs, and performance-based incentive compensation.
Sales and marketing expenses
Sales and marketing expenses for the
six months ended
June 30, 2018
increased
to
$323 million
compared with
$314 million
for the same period one year ago, and decreased to
45.8%
of net sales compared with
46.2%
of net sales last year. The
0.4
ppt. decrease in the sales and marketing expense rate was mainly due to the leveraging impact of the 4% net sales increase (see net sales commentary above).
General and administrative expenses
General and administrative (G&A) expenses totaled
$61 million
, or
8.6%
of net sales, for the
six months ended
June 30, 2018
, compared with
$63 million
, or
9.2%
of net sales, in the prior-year period. The
$2 million
decrease in G&A expenses consisted primarily of the following: (i) a $0.8 million decrease in employee compensation resulting from a year-over-year decrease in performance-based incentive compensation; and (ii) a $1.2 million net decrease in miscellaneous other expenses. The G&A expense rate decreased by 0.6 ppt. in the current-year period compared with the same period one year ago due to the decrease in expenses discussed above and leveraging impact of the
4%
sales increase (see net sales commentary above).
Income tax expense
Income tax expense was $
3 million
for the
six months ended
June 30, 2018
, compared with
$9 million
for the same period one year ago. The effective tax rate for the
six months ended
June 30, 2018
was
10.1%
compared with
26.8%
for the prior-year period reflecting the changes associate with the Tax Cuts and Jobs Act, including a $2.9 million increase in the 2017 provisional tax benefit. Both periods' tax expense and effective tax rates included stock-based compensation excess tax benefits. See Note 12,
Income Taxes
, for further information.
18
Liquidity and Capital Resources
Managing our liquidity and capital resources is an important part of our commitment to deliver superior shareholder value. Our primary sources of liquidity are cash flows provided by operating activities and cash available under our $300 million revolving credit facility. The cash generated from ongoing operations, and cash available under our revolving credit facility are expected to be adequate to maintain operations and fund anticipated expansion and strategic initiatives for the foreseeable future.
As of
June 30, 2018
, cash and cash equivalents totaled
$2.4 million
compared with
$3.7 million
as of
December 30, 2017
. Available borrowing capacity under our revolving credit facility was
$114 million
at June 30, 2018. The
$1.2 million
decrease
in cash, cash equivalents and restricted cash was primarily due to
$29 million
of cash provided by operating activities and a $133 million increase in short-term borrowings, which was more than offset by
$21 million
of cash used to purchase property and equipment, and
$143 million
of cash used to repurchase our common stock (
$140 million
under our Board-approved share repurchase program and
$3 million
in connection with the vesting of employee restricted stock grants).
The following table summarizes our cash flows (dollars in millions). Amounts may not add due to rounding differences:
|
|
Six Months Ended
|
|||||||
|
|
June 30,
2018 |
July 1,
2017 |
||||||
|
Total cash provided by (used in):
|
|
|
||||||
|
Operating activities
|
$
|
29.1
|
|
$
|
88.8
|
|
||
|
Investing activities
|
(21.3
|
)
|
(27.1
|
)
|
||||
|
Financing activities
|
(9.1
|
)
|
(74.4
|
)
|
||||
|
Net decrease in cash, cash equivalents and restricted cash
|
$
|
(1.2
|
)
|
$
|
(12.7
|
)
|
||
Cash provided by operating activities for the
six months ended
June 30, 2018
was
$29 million
compared with
$89 million
for the
six months ended
July 1, 2017
. Significant components of the year-over-year change in cash provided by operating activities included: (i) a $20 million fluctuation in accrued compensation and benefits that primarily resulted from year-over-year changes in company-wide performance-based incentive compensation that was accrued and paid in the two comparable periods (lower incentive compensation paid 2017; lower incentive compensation accrued in the first six months of 2018); (ii) a $19 million fluctuation in customer prepayments resulting mainly from higher than normal prepayments at July 1, 2017 (delayed deliveries and shipments due to an inventory shortage from one of our new suppliers); and (iii) an $11 million fluctuation in inventory resulting from temporarily higher than normal inventory levels at June 30, 2018 (to support the roll-out of new products, including our new Sleep Number 360 smart beds) and temporarily lower than normal inventory levels at July 1, 2017 (due to an inventory shortage from one of our new suppliers).
Net cash
used in
investing activities to purchase property and equipment was
$21 million
for the
six months ended
June 30, 2018
, compared with
$27 million
for the same period one year ago.
Net cash
used in
financing activities was
$9 million
for the
six months ended
June 30, 2018
, compared with
$74 million
for the same period one year ago. During the
six months ended
June 30, 2018
, we repurchased
$143 million
of our stock (
$140 million
under our Board-approved share repurchase program and
$3 million
in connection with the vesting of employee restricted stock awards) compared with
$80 million
(
$75 million
under our Board-approved share repurchase program and
$5 million
in connection with the vesting of employee restricted stock awards) during the same period one year ago. Short-term borrowings increased by
$133 million
during the current-year period primarily due to the increase in borrowings under our revolving credit facility to $183 million, partially offset by a decrease in book overdrafts which are included in the net change in short-term borrowings.
Under our Board-approved share repurchase program, we repurchased
4.2 million
shares at a cost of
$140 million
(an average of
$33.22
per share) during the
six months ended
June 30, 2018
. During the
six months ended
July 1, 2017
, we repurchased
3.1 million
shares at a cost of
$75 million
(an average of
$24.57
per share). As of June 30, 2018, the remaining authorization under our Board-approved share repurchase program was $325 million. There is no expiration date governing the period over which we can repurchase shares.
In February 2018, we amended our revolving credit facility to increase our net aggregate availability from $153 million to
$300 million
. We maintained the accordion feature which allows us to increase the amount of the credit facility from
$300 million
to
$450 million
, subject to lenders' approval. There were no other changes to the credit agreement's terms and conditions.
19
As of
June 30, 2018
, we had
$183 million
of borrowings under credit facility and
$3 million
in outstanding letters of credit. Our available borrowing capacity was
$114 million
. We were in compliance with all financial covenants. The credit facility matures in
February 2023
. The credit agreement provides the lenders with a collateral security interest in substantially all of our assets and those of our subsidiaries and requires us to comply with, among other things, a maximum leverage ratio and a minimum interest coverage ratio. Under the terms of the credit agreement we pay a variable rate of interest and a commitment fee based on our leverage ratio. The credit facility is for general corporate purposes and is utilized to meet our seasonal working capital requirements.
We have an agreement with Synchrony Bank to offer qualified customers revolving credit arrangements to finance purchases from us (Synchrony Agreement). The Synchrony Agreement contains financial covenants consistent with our credit facility, including a maximum leverage ratio and a minimum interest coverage ratio. As of
June 30, 2018
, we were in compliance with all financial covenants.
Under the terms of the Synchrony Agreement, Synchrony Bank sets the minimum acceptable credit ratings, the interest rates, fees and all other terms and conditions of the customer accounts, including collection policies and procedures, and is the owner of the accounts.
Non-GAAP Data
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure.
Our Adjusted EBITDA calculations are as follows (dollars in thousands):
|
|
Three Months Ended
|
Trailing-Twelve
Months Ended
|
||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||||||
|
Net income (loss)
|
$
|
3,744
|
|
$
|
(778
|
)
|
$
|
65,686
|
|
$
|
60,715
|
|
||||
|
Income tax (benefit) expense
|
(3,111
|
)
|
(2,565
|
)
|
20,014
|
|
25,597
|
|
||||||||
|
Interest expense
|
1,454
|
|
288
|
|
2,486
|
|
924
|
|
||||||||
|
Depreciation and amortization
|
15,326
|
|
14,918
|
|
60,945
|
|
60,170
|
|
||||||||
|
Stock-based compensation
|
3,658
|
|
4,172
|
|
14,629
|
|
12,231
|
|
||||||||
|
Asset impairments
|
85
|
|
2
|
|
327
|
|
47
|
|
||||||||
|
Adjusted EBITDA
|
$
|
21,156
|
|
$
|
16,037
|
|
$
|
164,087
|
|
$
|
159,684
|
|
||||
Free Cash Flow
Our “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, “net cash provided by operating activities,” or GAAP financial data. However, we are providing this information as we believe it facilitates analysis for investors and financial analysts.
The following table summarizes our free cash flow calculations (dollars in thousands):
|
|
Six Months Ended
|
Trailing-Twelve
Months Ended
|
||||||||||||||
|
|
June 30,
2018 |
July 1,
2017 |
June 30,
2018 |
July 1,
2017 |
||||||||||||
|
Net cash provided by operating activities
|
$
|
29,131
|
|
$
|
88,807
|
|
$
|
112,931
|
|
$
|
193,332
|
|
||||
|
Subtract: Purchases of property and equipment
|
21,341
|
|
27,132
|
|
54,038
|
|
61,220
|
|
||||||||
|
Free cash flow
|
$
|
7,790
|
|
$
|
61,675
|
|
$
|
58,893
|
|
$
|
132,112
|
|
||||
20
Non-GAAP Data
(continued)
Return on Invested Capital (ROIC)
(dollars in thousands)
ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our invested capital. Management believes ROIC is also a useful metric for investors and financial analysts. We compute ROIC as outlined below. Our definition and calculation of ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile net operating profit after taxes (NOPAT) and total invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:
|
|
Trailing-Twelve
Months Ended
|
|||||||
|
|
June 30,
2018 |
July 1,
2017 |
||||||
|
Net operating profit after taxes (NOPAT)
|
||||||||
|
Operating income
|
$
|
88,135
|
|
$
|
87,124
|
|
||
|
Add: Rent expense
(1)
|
76,215
|
|
70,815
|
|
||||
|
Add: Interest income
|
50
|
|
112
|
|
||||
|
Less: Depreciation on capitalized operating leases
(2)
|
(19,640
|
)
|
(17,956
|
)
|
||||
|
Less: Income taxes
(3)
|
(43,934
|
)
|
(46,095
|
)
|
||||
|
NOPAT
|
$
|
100,826
|
|
$
|
94,000
|
|
||
|
Average invested capital
|
||||||||
|
Total equity
|
$
|
(21,154
|
)
|
$
|
114,439
|
|
||
|
Add: Long-term debt
(4)
|
183,405
|
|
—
|
|
||||
|
Add: Capitalized operating lease obligations
(5)
|
609,720
|
|
566,520
|
|
||||
|
Total invested capital at end of period
|
$
|
771,971
|
|
$
|
680,959
|
|
||
|
Average invested capital
(6)
|
$
|
705,575
|
|
$
|
690,524
|
|
||
|
Return on invested capital (ROIC)
(7)
|
14.3
|
%
|
13.6
|
%
|
||||
___________________
(1)
Rent expense is added back to operating income to show the impact of owning versus leasing the related assets.
(2)
Depreciation is based on the average of the last five fiscal quarters' ending capitalized operating lease obligations (see note 6) for the respective reporting periods with an assumed thirty-year useful life. This is subtracted from operating income to illustrate the impact of owning versus leasing the related assets.
(3)
Reflects annual effective income tax rates, before discrete adjustments, of
30.3%
and
32.9%
for
2018
and
2017
, respectively.
(4)
Long-term debt includes existing capital lease obligations, if applicable. In conjunction with increasing our revolving credit facility to $300 million in the first quarter of 2018, we include borrowings under that agreement, including borrowings classified as short term.
(5)
A multiple of eight times annual rent expense is used as an estimate for capitalizing our operating lease obligations. The methodology utilized aligns with the methodology of a nationally recognized credit rating agency.
(6)
Average invested capital represents the average of the last five fiscal quarters' ending invested capital balances.
(7)
ROIC equals NOPAT divided by average invested capital.
Note - Our ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.
21
Off-Balance-Sheet Arrangements and Contractual Obligations
As of
June 30, 2018
, we were not involved in any unconsolidated special purpose entity transactions. Other than our operating leases and
$3 million
in outstanding letters of credit, we do not have any off-balance-sheet financing.
There has been no material changes in our contractual obligations, other than in the ordinary course of business, since the end of
fiscal 2017
. See Note 6,
Credit Agreement
, of the Notes to our Condensed Consolidated Financial Statements for information regarding our credit agreement. See our Annual Report on Form 10-K for the fiscal year ended
December 30, 2017
for additional information regarding our other contractual obligations.
Critical Accounting Policies
We discuss our critical accounting policies and estimates in
Management’s Discussion and Analysis of Financial Condition and Results of Operations
in our Annual Report on Form 10-K for the fiscal year ended
December 30, 2017
. Other than the adoption of the new revenue recognition guidance as described in Note 1,
Business and Summary of Significant Accounting Policies and
Note 2
, Revenue Recognition,
there were no other significant changes in our critical accounting policies since the end of
fiscal 2017
.
We are exposed to changes in market short-term interest rates that will impact our net interest expense. If overall interest rates were one percentage point higher than current rates, net income would decrease by
$1.4 million
based on the
$183 million
of borrowings under our revolving credit facility at
June 30, 2018
. We do not manage our investment interest-rate volatility risk through the use of derivative instruments.
Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.
Changes in Internal Controls
There were no changes in our internal control over financial reporting during the fiscal quarter ended
June 30, 2018
, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
22
We are involved from time to time in various legal proceedings arising in the ordinary course of our business, including primarily commercial, product liability, employment and intellectual property claims. In accordance with generally accepted accounting principles in the United States, we record a liability in our consolidated financial statements with respect to any of these matters when it is both probable that a liability has been incurred and the amount of the liability can be reasonably estimated. With respect to currently pending legal proceedings, we have not established an estimated range of reasonably possible additional losses either because we believe that we have valid defenses to claims asserted against us or the proceeding has not advanced to a stage of discovery that would enable us to establish an estimate. We currently do not expect the outcome of these matters to have a material effect on our consolidated results of operations, financial position or cash flows. Litigation, however, is inherently unpredictable, and it is possible that the ultimate outcome of one or more claims asserted against us could adversely impact our consolidated results of operations, financial position or cash flows. We expense legal costs as incurred.
On January 12, 2015, Plaintiffs David and Katina Spade commenced a purported class action lawsuit in New Jersey state court against Sleep Number alleging that Sleep Number violated New Jersey consumer statutes by failing to provide to purchasing consumers certain disclosures required by the New Jersey Furniture Regulations. It is undisputed that plaintiffs suffered no actual damages or in any way relied upon or were impacted by the alleged omissions. Nonetheless, on behalf of a purported class of New Jersey purchasers of Sleep Number beds and bases, plaintiffs seek to recover a $100 statutory fine for each alleged omission, along with attorneys’ fees and costs. Sleep Number removed the case to the United States District Court for the District of New Jersey, which subsequently granted Sleep Number’s motion to dismiss. Plaintiffs appealed to the United States Court of Appeals for the Third Circuit, which certified two questions of law to the New Jersey Supreme Court relating to whether plaintiffs who have suffered no actual injury may bring claims. The New Jersey Supreme Court accepted the certified questions and on April 16, 2018, ruled in our favor on one of the two questions, holding that a consumer only has standing to bring a claim under the relevant statute if the consumer has been harmed by the defendant's conduct. The Third Circuit has remanded the case to the federal district court for further analysis consistent with the New Jersey Supreme Court’s opinion. As a result, we expect that the federal district court will dismiss any claims that Plaintiffs attempt to pursue consistent with the guidance set forth by the New Jersey Supreme Court.
Our business, financial condition and operating results are subject to a number of risks and uncertainties, including both those that are specific to our business and others that affect all businesses operating in a global environment. Investors should carefully consider the information in this report under the heading, “
Management’s Discussion and Analysis of Financial Condition and Results of Operations
” and also the information under the heading, “
Risk Factors
” in our most recent Annual Report on Form 10-K. The risk factors discussed in the Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q do not identify all risks that we face because our business operations could also be affected by additional risk factors that are not presently known to us or that we currently consider to be immaterial to our operations.
23
|
(a) – (b)
|
Not applicable.
|
|
(c)
|
Issuer Purchases of Equity Securities
|
|
Fiscal Period
|
Total
Number
of Shares
Purchased
(1)(2)
|
Average
Price
Paid
per Share
|
Total Number
of Shares
Purchased as
|
Approximate
Dollar Value
of Shares that
May Yet Be
Purchased
Under the
Plans or
Programs
(3)
|
||||||||||
|
April 1, 2018 through April 28, 2018
|
616,438
|
|
$
|
33.19
|
|
610,258
|
|
$
|
369,757,000
|
|
||||
|
April 29, 2018 through May 26, 2018
|
712,304
|
|
28.60
|
|
711,933
|
|
349,396,000
|
|
||||||
|
May 27, 2018 through June 30, 2018
|
820,816
|
|
29.80
|
|
818,559
|
|
325,000,000
|
|
||||||
|
Total
|
2,149,558
|
|
$
|
30.37
|
|
2,140,750
|
|
$
|
325,000,000
|
|
||||
|
(1)
|
Under our Board-approved $500 million share repurchase program, we repurchased
2,140,750
shares of our common stock at a cost of
$65 million
(based on trade dates) during the three months ended
June 30, 2018
.
|
|
(2)
|
In connection with the vesting of employee restricted stock grants, we also repurchased
8,808
shares of our common stock at a cost of
$0.3 million
during the three months ended
June 30, 2018
.
|
|
(3)
|
There is no expiration date governing the period over which we can repurchase shares under our Board-approved share repurchase program. Any repurchased shares are constructively retired and returned to an unissued status.
|
Not applicable.
Not applicable.
Not applicable.
24
|
Exhibit
Number
|
|
Description
|
|
Method of Filing
|
|
10.1
|
Filed herewith
|
|||
|
31.1
|
Filed herewith
|
|||
|
31.2
|
|
|
Filed herewith
|
|
|
32.1
|
|
|
Furnished herewith
(2)
|
|
|
32.2
|
|
|
Furnished herewith
(2)
|
|
|
101
|
|
The following financial information from the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2018, filed with the SEC on August 3, 2018, formatted in eXtensible Business Reporting Language: (i) Condensed Consolidated Balance Sheets as of June 30, 2018 and December 30, 2017; (ii) Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2018 and July 1, 2017; (iii) Condensed Consolidated Statement of Shareholders' (Deficit) Equity for the six months ended June 30, 2018; (iv) Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and July 1, 2017; and (v) Notes to Condensed Consolidated Financial Statements.
|
|
Filed herewith
|
(1)
Confidential treatment has been requested by the issuer with respect to designated portions contained within this document. Such portions have been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.
(2)
This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as amended, (15 U.S.C. 78r) or otherwise subject to the liability of that section. Such exhibit will not be deemed to be incorporated by reference into any document filed under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, except as otherwise expressly stated in any such filing.
25
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
SLEEP NUMBER CORPORATION
|
|
|||
|
|
(Registrant)
|
|
|||
|
|
|
|
|||
|
Dated:
|
August 3, 2018
|
By:
|
|
/s/ Shelly R. Ibach
|
|
|
|
|
|
Shelly R. Ibach
|
|
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
(principal executive officer)
|
|
|
|
|
By:
|
|
/s/ Robert J. Poirier
|
|
|
|
|
|
|
Robert J. Poirier
|
|
|
|
|
|
|
Chief Accounting Officer
|
|
|
|
|
|
|
(principal accounting officer)
|
|
|
26
TABLE OF CONTENTS
Part I: Financial InformationItem 1. Financial StatementsItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart Ii: Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsPart OfItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits